—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Argen-X (ARGX.BR) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 64 out of 100 (momentum 74 · quality 75 · valuation 29), as of 2026-11-03.
  • Signal: Pullback inside an uptrend stack — Trades -5.2% vs the 50-day and +5.4% vs the 200-day average, 15.2% below the 52-week high and +37.9% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Argen-X trades 5.2% below its 50-day and 5.4% above its 200-day moving average. (as of 2026-11-02)

Argen-X develops antibody therapies for autoimmune disease, selling VYVGART and VYVGART HYTRULO for conditions such as myasthenia gravis and CIDP. Its pipeline extends the same FcRn-blocking approach into other immune disorders and adds candidates aimed at inflammation and antibody-driven disease.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ARGX.BR overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -5.2% vs the 50-day and +5.4% vs the 200-day average, 15.2% below the 52-week high and +37.9% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ARGX.BR chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on ARGX.BR?

Pullback inside an uptrend stack — Trades -5.2% vs the 50-day and +5.4% vs the 200-day average, 15.2% below the 52-week high and +37.9% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ARGX.BR above its 50-day and 200-day moving averages?

As of 2026-11-02, Argen-X trades -5.2% below its 50-day and +5.4% above its 200-day average, with the 20-day +1.8% away.

How far is ARGX.BR from its 52-week high?

15.2% below the 52-week high and 37.9% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.